Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
3.830
+0.130 (3.51%)
At close: May 12, 2025, 4:00 PM
4.020
+0.190 (4.96%)
After-hours: May 12, 2025, 6:10 PM EDT
Silence Therapeutics Stock Forecast
SLN's stock price has decreased by -81.57% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Silence Therapeutics stock have an average target of 32.6, with a low estimate of 3.00 and a high estimate of 75. The average target predicts an increase of 751.17% from the current stock price of 3.83.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Silence Therapeutics stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $4 → $3 | Strong Sell | Maintains | $4 → $3 | -21.67% | May 9, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $45 → $25 | Buy | Maintains | $45 → $25 | +552.74% | May 9, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $55 → $35 | Strong Buy | Maintains | $55 → $35 | +813.84% | May 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +1,858.22% | Mar 7, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $49 → $45 | Buy | Maintains | $49 → $45 | +1,074.93% | Mar 5, 2025 |
Financial Forecast
Revenue This Year
32.34M
from 43.26M
Decreased by -25.23%
Revenue Next Year
n/a
from 32.34M
EPS This Year
n/a
from -0.98
EPS Next Year
n/a
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 |
|---|---|
| High | 74.5M |
| Avg | 32.3M |
| Low | 10.3M |
Revenue Growth
| Revenue Growth | 2025 |
|---|---|
| High | 72.2% |
| Avg | -25.2% |
| Low | -76.3% |
EPS Forecast
| EPS |
|---|
| High |
| Avg |
| Low |
EPS Growth
| EPS Growth |
|---|
| High |
| Avg |
| Low |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.